For example, LPS injection was reported to decrease the protein and mRNA expression of Glucose transporter type 4 (Glut 4), the primary transporter for glucose uptake in adipose tissues, and induces symptoms of type 2 diabetes mellitus such as increased fasting blood glucose, impaired glucose tolerance, and insulin resistance [1,2,3,4]. This evidence concerns the gene SLC2A4 and type 2 diabetes mellitus.